Clinical Trial Update: Ramatroban/Montelukast Versus Montelukast/Placebo on the Early Allergic Reaction in Asthma Sensitive to House Dust Mite [Phase 2, Phase 3]

View source ↗

Summary

This Phase 2/3 trial evaluating ramatroban/montelukast versus montelukast/placebo for early allergic reactions in house-dust mite–sensitive asthma has been with…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Asthma

Drugs mentioned

• Montelukast (Montelukast)
• Ramatroban (ramatroban)

Snippet

Sponsor: Research Center Borstel | Conditions: Asthma | Phase 2, Phase 3 | Status: WITHDRAWN